Inogen | INGN - Sales Revenues


Inogen reported $74.93M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Philips EUR 4.36B 450M Jun/2026
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
X T L Biopharmaceuticals USD 289K 127K Dec/2024
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026